Related Experiment Video
Updated: Jul 14, 2026
13:46
A Facile and Eco-friendly Route to Fabricate Poly(Lactic Acid) Scaffolds with Graded Pore Size
Published on: October 17, 2016
An optimized beta-tricalcium phosphate and agarose scaffold fabrication technique
1Departamento de Química Inorgánica y Bioinorgánica, Facultad de Farmacia, Universidad Complutense de Madrid, 28040 Madrid, Spain.
Journal of Biomedical Materials Research. Part A
|June 30, 2007
Summary
Researchers developed injectable biodegradable scaffolds using beta-tricalcium phosphate and agarose. Vancomycin was successfully incorporated, showing tunable drug release for improved bone graft performance.
Area of Science:
- Biomaterials Science
- Regenerative Medicine
- Drug Delivery Systems
Background:
- Biodegradable scaffolds are crucial for bone tissue engineering.
- Incorporating therapeutic agents can enhance graft efficacy.
- Beta-tricalcium phosphate (β-TCP) and agarose offer promising scaffold properties.
Purpose of the Study:
- To develop injectable, biodegradable scaffolds using β-TCP and agarose.
- To incorporate vancomycin into these scaffolds without compromising structural integrity.
- To investigate the influence of scaffold composition on drug release characteristics.
Main Methods:
- Scaffolds were fabricated using a thermal gelation method.
- Vancomycin was incorporated during the scaffold preparation phase.
- Swelling behavior and in vitro drug release kinetics were analyzed.
Main Results:
- Injectable scaffolds composed of β-TCP and agarose were successfully prepared.
- Vancomycin incorporation did not affect scaffold consolidation.
- Scaffold swelling and vancomycin release rates were dependent on agarose and β-TCP content.
Conclusions:
- The developed injectable scaffolds show potential for bone tissue engineering with controlled drug delivery.
- Scaffold composition can be tailored to modulate drug release profiles.
- This method offers a promising approach for enhancing bone graft performance with therapeutic agents.
